Abstract

In patients with heart failure and cardiac dyssynchrony, cardiac resynchronization improves symptoms and the quality of life and reduces complications and the risk of death. These benefits are in addition to those afforded by standard pharmacologic therapy. The implantation of a cardiac-resynchronization device should routinely be considered in such patients.

Keywords

MedicineCardiac resynchronization therapyHeart failureCardiologyInternal medicineHazard ratioEjection fractionVentricular dyssynchronyConfidence intervalClinical endpointRandomized controlled trial

Affiliated Institutions

Related Publications

Publication Info

Year
2005
Type
article
Volume
352
Issue
15
Pages
1539-1549
Citations
6169
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

6169
OpenAlex

Cite This

John G.F. Cleland, Jean‐Claude Daubert, Erland Erdmann et al. (2005). The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. New England Journal of Medicine , 352 (15) , 1539-1549. https://doi.org/10.1056/nejmoa050496

Identifiers

DOI
10.1056/nejmoa050496